← Back to Search

Decision aid with personalized message for Cancer Screening Tests

N/A
Waitlist Available
Research Sponsored by Indiana University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months after patient enrollment
Awards & highlights

Study Summary

This trial is studying a decision aid to help patients and providers choose between colonoscopy and a non-invasive test for colorectal cancer.

Eligible Conditions
  • Cancer Screening Tests

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months after patient enrollment
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months after patient enrollment for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Decision Quality assessed using the multi-dimensional measure of informed consent (MMIC) which incorporates knowledge, intent, and behavior.
Number of patients who complete colorectal cancer screening
Secondary outcome measures
Colorectal Cancer (CRC) Screening Intention
Colorectal Cancer (CRC) Screening Test Choice
Decision Conflict Scale
+4 more

Trial Design

4Treatment groups
Experimental Treatment
Active Control
Group I: Group 4Experimental Treatment2 Interventions
Patients view decision aid with the personalized message and whose providers receive the personalized message.
Group II: Group 3Experimental Treatment2 Interventions
Patient view decision aid without the personalized message and whose providers receive the personalized message.
Group III: Group 2Experimental Treatment2 Interventions
Patients view decision aid with personalized message and whose providers do not receive the personalized message.
Group IV: Group 1Active Control2 Interventions
Patients view decision aid without personalized message and whose providers do not receive the personalized message.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Decision aid with personalized message
2021
N/A
~1440
Provider notification with personalized message
2021
N/A
~1440
Decision aid without personalized message
2021
N/A
~1440
Provider notification without personalized message
2021
N/A
~1440

Find a Location

Who is running the clinical trial?

Indiana UniversityLead Sponsor
975 Previous Clinical Trials
981,858 Total Patients Enrolled
Patient-Centered Outcomes Research InstituteOTHER
548 Previous Clinical Trials
29,995,147 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this trial include seniors aged 85 or above?

"In order to take part in this trial, participants must fall between the ages of 50 and 75. 30 studies are available for minors while 849 trials cater specifically to senior citizens."

Answered by AI

What is the cap of participants in this research project?

"Affirmative. Data posted on clinicaltrials.gov indicates that enrolment for this medical experiment is ongoing; the study was first made available to patients on January 19th 2021 and recently updated in July 7th 2022 with a goal of recruiting 1300 people from 1 site."

Answered by AI

What results are hoped for from this experiment?

"The primary goal of this clinical trial, which is gauged over a 6-month period post enrolment, is to assess Decision Quality utilizing the multi-dimensional measure of informed consent (MMIC) that encompasses knowledge, intent and behaviour. Additional outcomes include CRC Screening Test Choice, Decision Conflict Scale and Number of providers who open their provider notification all as specified in detail by the study protocol."

Answered by AI

To what extent is participation in this trial open?

"This research study is looking to recruit 1300 volunteers aged between 50 and 75 with a diagnosis of colorectal cancer. Furthermore, the potential participants must not have had any colon-related test in the past 5 years or Cologuard within 3 years; additionally they should have an appointment scheduled at one of the partner research sites with either an MD, DO, NP or PA."

Answered by AI

Are there current openings in this research experiment?

"Affirmative, the information on clinicaltrials.gov confirms that this research study is presently accepting patients. The trial was first posted on January 19th 2021 and recently modified on July 7th 2022. 1 medical site will be enrolling 1300 participants in total."

Answered by AI
~345 spots leftby Mar 2025